BeyondSpring, Inc. (BYSI) Financials

BYSI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 32.9 million 47.6 million
2023-06-30 32.9 million 47.6 million
2023-03-31 46.2 million 49.2 million
2022-12-31 63.8 million 62.7 million

BYSI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-06-30 ? ?
2023-03-31 3.7 million 833000
2022-12-31 ? ?

BYSI Net Income

No data available :(

BYSI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 15.4 million - -
2023-06-30 - - 4.5 million
2023-03-31 37.3 million - -
2022-12-31 51.9 million - 5.0 million

BYSI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 39.0 million
2023-06-30 39.0 million
2023-03-31 39.1 million
2022-12-31 39.1 million

BYSI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.6 million 2.6 million -
2023-06-30 - - - -
2023-03-31 2.8 million 5.8 million 2.8 million -
2022-12-31 - 7.0 million 3.7 million -

BYSI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 437500 -
2023-06-30 - -
2023-03-31 337500 -
2022-12-31 338000 -

BYSI

Price: $2.25

52 week price:
0.65
4.00

Earnings Per Share: -0.71 USD

P/E Ratio: -1.90

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 157900

Ebitda: -18.6 million

Market Capitalization: 74.5 million

Links: